JJ
Therapeutic Areas
Sigyn Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Sigyn CardioDialysis™ | Reduction of Major Adverse Cardiovascular Events (MACE) | Clinical-Stage |
| ImmunePrep™ | Optimization of immunotherapeutic antibody delivery | Preclinical |
| ChemoPrep™ | Enhanced targeted delivery of chemotherapy | Preclinical |
| ChemoPure™ | Reduction of chemotherapy-induced toxicity | Preclinical |